PharmaShots Weekly Snapshot (December 02-06, 2019)

1.  Sage Therapeutics Reports Results of SAGE-217 in P-III MOUNTAIN Study for Major Depressive Disorders

Published: Dec 05, 2019 | Tags: Sage Therapeutics, Reports, Results, SAGE-217, P-III, MOUNTAIN Study, Major Depressive Disorders

 2. UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-To-Severe Chronic Plaque Psoriasis

Published: Dec 06, 2019 | Tags: UCB, Reports, Results, Bimekizumab, P-III, BE SURE, Study, Moderate-To-Severe, Chronic Plaque Psoriasis

3.  Bio-Thera Reports NMPA’s Acceptance of IND for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)

Published: Dec 04, 2019 | Tags: Bio-Thera, Reports, NMPA, Acceptance, IND, BAT2206, Proposed Biosimilar, Stelara, Ustekinumab

4.  Bayer And Simulations Plus Collaborate to Advance ADMET Predictor for Improving Data Integrity in Drug Discovery

Published: Dec 05, 2019 | Tags: Bayer, Simulations Plus, Collaborate, Advance, ADMET Predictor, Data Integrity, Drug Discovery

5. Y-mAbs Reports EMA’s Acceptance of Pediatric Investigation Plan for Omburtamab

Published: Dec 05, 2019 | Tags: Y-mAbs, EMA, Approval, Pediatric Investigation Plan, Omburtamab

6.  Novartis Reports Results of QMF149 in P-III PALLADIUM Study for Patients with Uncontrolled Asthma

Published: Dec 06, 2019 | Tags: Novartis, Reports Results, QMF149, P-III, PALLADIUM Study, Uncontrolled Asthma

7. FDA and NIH Launch CURE ID Crowdsourcing App for Patients with Infectious Diseases

Published: Dec 05, 2019 | Tags: FDA, NIH, Launch, CURE ID, Crowdsourcing App, Infectious Diseases

8. Cerecor to Acquire Aevi Genomic Medicine for ~$22.6M

Published:  Dec 05, 2019 | Tags: Cerecor, Acquire, Aevi Genomic Medicine, $22.6M

9. AstraZeneca Signs an Agreement with Gatehouse Bio to Identify New Therapies Targeting Respiratory and Cardiovascular Diseases

Published: Dec 04, 2019 | Tags: AstraZeneca, Signs, Agreement, Gatehouse Bio, Identify, New Therapies, Targeting, Respiratory, Cardiovascular Diseases

10. Bayer Collaborates with Children’s Hospital of Philadelphia to Develop Oral Non-Replacement Therapy for the Treatment of Hemophilia

Published: Dec 05, 2019 | Tags: Bayer, Collaborates, CHOP, Develop, Oral Non-Replacement Therapy, Hemophilia A and B

11.  Philips Collaborates with Humana to Deliver Remote Monitoring Capabilities to Select Medicare Advantage Members

Published: Dec 04, 2019 | Tags: Philips, Collaborates, Humana, Deliver, Remote, Monitoring Capabilities, Medicare Advantage Members

12.  AstraZeneca and MSD’s Lynparza (olaparib) Receive NMPA’s Approval as 1L Maintenance Therapy for BRCA-Mutated Advanced Ovarian Cancer

Published: Dec 05, 2019 | Tags: AstraZeneca, MSD, Lynparza, olaparib, Receive, NMPA, Approval, 1L, Maintenance Therapy, BRCA-Mutated Advanced Ovarian Cancer

13. Takeda Collaborates with Enzyre to Develop Diagnostic Device to Regulate Coagulation Status in Patients with Hemophilia at Home

Published: Dec 05, 2019 | Tags: Takeda, Collaborates, Enzyre, Develop, Diagnostic Device, Regulate, Coagulation Status, Patients, Hemophilia, Home

14.  Novartis Highlights its Blockbuster Portfolio at R&D Day 2019

Published: Dec 05, 2019 | Tags: Novartis, Highlights, Blockbuster Pipeline, 25+, Products, R&D Day 2019

15. Novartis Collaborates with Amazon to Leverage Cloud Services for its Business Operations

Published: Dec 04, 2019 | Tags: Novartis, Collaborates, Amazon, Leverage, Cloud Services, Business Operations

16. Lannett Reports Results of Biosimilar Insulin Glargine in Human Clinical Study to Treat Patients with Type 2 Diabetes

Published: Dec 04, 2019 | Tags:  Lannett, Reports, Results, Biosimilar Insulin Glargine, Human Clinical Study, Treat, Patients, Type 2 Diabetes

17. LEO Pharma Collaborates with Portal Instruments to Develop Needle-Free Drug Delivery Device

Published: Dec 04, 2019 | Tags: LEO Pharma, Collaborate, Portal Instruments, Develop, Needle-Free Drug Delivery Device

18. BMS’ Orencia (abatacept) Receive the FDA’s Breakthrough Therapy Designation to Prevent Acute Graft-Versus-Host Disease After Stem Cell Transplant

Published: Dec 04, 2019 | Tags: Myovant Sciences, Reports, Results, Relugolix, P-III, HERO Study, Men, Advanced Prostate Cancer

19.  Eris Lifesciences Acquires Novartis’ Zomelis (vildagliptin) in India for $13M

Published: Dec 03, 2019 | Tags: Eris Lifesciences, Acquires, Novartis, Zomelis, vildagliptin, India, $13M

20.  Veracyte Signs an Exclusive License Agreement with NanoString for its nCounter FLEX System

Published: Dec 03, 2019 | Tags: Veracyte, Signs, Exclusive, License, Agreement, NanoString, nCounter FLEX System

21. Johnson & Johnson Vision Launches TECNIS Toric II 1-Piece IOL as a New Monofocal Option for Cataract Patients with Astigmatism in the US

Published: Dec 03, 2019 | Tags: Johnson N Johnson Vision, Launches, TECNIS Toric II 1-Piece IOL, New Monofocal Option, Cataract Patients, Astigmatism, US

22.  Roche’s Tecentriq + CT (abraxane and carboplatin) Receive the US FDA’s Approval for the Initial Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer

Published: Dec 04, 2019 | Tags: Roche, Tecentriq, CT, abraxane, carboplatin, Receive, US, FDA, Approval, Treatment, Metastatic Non-Squamous Non-Small Cell Lung Cancer

23.  Merck KGaA and Ping An Good Doctor Collaborate to Support Health Management in China

Published: Dec 04, 2019 | Tags: Merck, Ping An Good Doctor, Collaborate, Support, Health Management, China

24.  Ethicon Launches VISTASEAL Fibrin Sealant (Human) for Sealing Off Bleeds During Surgery

Published: Dec 03, 2019 | Tags:  Ethicon, Launches, VISTASEAL Fibrin Sealant (Human), Sealing Off, Bleeds, Surgery

25.  StemoniX Collaborates with Atomwise to Form a Joint Venture Targeting Rett Syndrome

Published: Dec 03, 2019 | Tags: StemoniX, Collaborates, Atomwise, Joint Venture, Targeting, Rett Syndrome

26. Kamada Collaborates with Alvotech to Commercialize its Six Biosimilar Products in Israel

Published: Dec 02, 2019 | Tags: Kamada, Collaborates, Alvotech, Commercialize, Six, Biosimilar, Products, Israel

27. GE Healthcare Signs an Agreement with Affidea to Deploy Digital Imaging Technologies

Published: Dec 02, 2019 | Tags: GE Healthcare, Signs, Agreement, Affidea, Deploy, Digital Imaging Technologies

28. Seattle Genetics and Astellas Collaborate with Merck to Evaluate Enfortumab Vedotin + Keytruda (pembrolizumab) for Metastatic Urothelial Cancer

Published: Dec 02, 2019 | Tags: Seattle Genetics, Astellas, Collaborate, Merck, Evaluate, Enfortumab Vedotin, Keytruda, pembrolizumab, Metastatic Urothelial Cancer

29.  Gene Techno Science Signs an Agreement with Kishi Kasei to Co-Develop Biosimilar of Aflibercept

Published: Dec 03, 2019 | Tags: Gene Techno Science, Signs, Agreement, Kishi Kasei, Co-Develop, Biosimilar, Aflibercept

30. AstraZeneca Divests Commercial Rights of Seroquel and Seroquel XR to Cheplapharm in the US and Canada

Published: Dec 03, 2019 | Tags: AstraZeneca, Divests, Commercial Rights, Seroquel, Seroquel XR, Cheplapharm, US, Canada

 31. STADA to Acquire Biopharma’s Pharmaceutical Prescription and Consumer Health Business to Expand Its Footprint in Ukraine

Published: Dec 02, 2019 | Tags: STADA, Acquire, Biopharma, Pharmaceutical Prescription, Consumer Health Business, Expand, Presence, Ukraine

32. Astellas to Acquire Audentes Therapeutics for $3B

Published: Dec 02, 2019 | Tags: Astellas, Acquire, Audentes Therapeutics, $3B

33. Baxter to Acquire Seprafilm Adhesion Barriers from Sanofi for $350M

Published: Dec 02, 2019 | Tags: Baxter, Expand, Advanced, Surgery Portfolio, Acquisition, Seprafilm Adhesion Barrier

34. Neurocrine Signs a License Agreement with Xenon to Develop Therapies for Epilepsy

Published: Dec 02, 2019 | Tags: Neurocrine Biosciences, Xenon Pharmaceuticals, Agreement, Develop, Epilepsy

35. Mylan and Biocon Launch Ogivri (biosimilar, trastuzumab) in the US

Published: Dec 02, 2019 | Tags: Mylan, Biocon, Launch, Trastuzumab, Biosimilar, Ogivri, trastuzumab-dkst, US

36. Merck’s Keytruda (pembrolizumab) Receives FDA’s Priority Review for sBLA to Treat High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC)

Published: Dec 02, 2019 | Tags: FDA, Priority Review, Merck,  sBLA, KEYTRUDA, pembrolizumab, High-Risk, Non-Muscle Invasive Bladder Cancer, NMIBC

38. Chipscreen Bioscience’s Epidaza (chidamide) Receives NMPA Approval for Breast Cancer Indication

Published: Nov 29, 2019 | Tags: Chipscreen Bioscience, Chidamide, Epidaza, Breast Cancer Indication, Receives

39. Fosun Pharma’s FN-1501 Receives the US FDA’s Orphan Drug Designation for Leukemia

Published: Dec 02, 2019 | Tags: Fosun Pharma, Leukemia, FN-1501, Receives, FDA, Orphan Drug Designation

40. Y-mAbs Reports Initiation of Rolling Review of BLA for Naxitamab to the US FDA to Treat Neuroblastoma

Published: Nov 29, 2019 s| Tags: Y-mAbs, Initiates, Rolling, BLA, US, FDA, Naxitamab, Neuroblastoma

41. Roche Reports Results of Satralizumab in P-III SAkuraSky Study to Treat Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Published: Dec 02, 2019 | Tags: Roche, Satralizumab, neuromyelitis optica spectrum disorder, P-III, SAkuraSky Study

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post